NCT06944249View on ClinicalTrials.gov

Effect of YAP1-inhibition in Surgical Wounds.

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 8, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

July 31, 2026

Conditions
Scar Formation
Interventions
DRUG

NaCl (placebo)

During the safety margin excision, the placebo (NaCl) will be injected into the wound before suturing.

DRUG

Verteporfin Injection

During the safety margin excision, the study drug (Verteporfin) will be injected into the wound before suturing.

All Listed Sponsors
collaborator

University of Geneva, Switzerland

OTHER

collaborator

University Hospital, Geneva

OTHER

lead

Jöri Pünchera

OTHER

NCT06944249 - Effect of YAP1-inhibition in Surgical Wounds. | Biotech Hunter | Biotech Hunter